Overview
Acute intestinal pseudo-obstruction (AIPO) is a syndrome characterized by symptoms mimicking mechanical bowel obstruction without an identifiable physical obstruction, affecting various age groups and often requiring intensive management. 1234Diagnosis
Clinical presentation includes abdominal distension, vomiting, pain, and altered bowel habits.
Radiographic studies (upper GI series, barium enema) are crucial, showing dilated bowel loops and abnormal transit.
Manometry may reveal abnormal motility patterns.
Biopsies may show ganglion cell presence or absence, aiding in diagnosis. 14Management
First-line treatments: Bowel rest, nasogastric decompression, and fluid/electrolyte management.
Adjunctive treatments: Neostigmine (or other cholinesterase inhibitors) for neuromuscular dysfunction, though dosing specifics are not provided.
Surgical intervention: Reserved for complications like bowel perforation, necrosis, or failure of medical management. 12Special Populations
Pediatrics: Higher mortality in early-onset cases (neonatal-onset) compared to late-onset cases; long-term nutritional support is critical. 1
Elderly: Susceptibility to Ogilvie syndrome (acute colonic pseudo-obstruction) with delayed recognition often due to institutional factors. 2
Comorbidities: Hydrocephalus with aqueduct stenosis may be associated with congenital idiopathic intestinal pseudo-obstruction, suggesting genetic factors play a role. 3Key Recommendations
Perform radiographic studies (upper GI series, barium enema) for definitive diagnosis of AIPO. (Evidence: Moderate 14)
Initiate conservative management with bowel rest and nasogastric suction; consider neostigmine for neuromuscular dysfunction. (Evidence: Moderate 12)
Early recognition and intervention are crucial in pediatric patients, particularly those with early-onset AIPO, to improve survival rates. (Evidence: Moderate 1)
In cases of suspected Ogilvie syndrome in elderly patients, prompt surgical consultation may be necessary due to high risk of complications. (Evidence: Weak 2)
Evaluate for underlying genetic conditions, such as L1CAM mutations, in pediatric patients with congenital AIPO and associated neurological abnormalities. (Evidence: Expert opinion 3)References
1 Tang P, Lu L, Yan W, Tao Y, Feng H, Cai W et al.. Long-term follow-up for pediatric intestinal pseudo-obstruction patients in China. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2023. link
2 Chabowski M, Chabowski M, Bieganski B, Kobecki J, Szponder M, Janczak D et al.. Idiopathic Dilatation of the Colon in a Nursing Home Resident, with a Suspected Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome). Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2019. link
3 Bott L, Boute O, Mention K, Vinchon M, Boman F, Gottrand F. Congenital idiopathic intestinal pseudo-obstruction and hydrocephalus with stenosis of the aqueduct of sylvius. American journal of medical genetics. Part A 2004. link
4 Byrne WJ, Cipel L, Euler AR, Halpin TC, Ament ME. Chronic idiopathic intestinal pseudo-obstruction syndrome in children--clinical characteristics and prognosis. The Journal of pediatrics 1977. link80371-5)